Literature DB >> 28330646

Is it time for a change in the approach to chemical burns? The role of Diphoterine® in the management of cutaneous and ocular chemical injuries.

C J Lewis1, A Al-Mousawi2, A Jha2, K P Allison2.   

Abstract

A multitude of household and occupational compounds have the potential to induce chemical burns to the eye and skin. Without prompt intervention, irreversible visual loss and disfigurement may prevail. Diphoterine® and Hexafluorine® are amphoteric and hypertonic chelating solutions used in the management of general chemical and hydrofluoric acid burns, respectively. They rapidly neutralise both acid and alkali agents without heat release and limit diffusion, making them superior to water irrigation alone. However, although Diphoterine® and Hexafluorine® uptake is slowly increasing in industrial workplaces, there is a paucity of education and use in both emergency departments and plastic surgery units worldwide. Herein, we present a case report of combined ocular and cutaneous acid burn treated with Diphoterine®, together with a review of the current supporting literature. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemical burn; Diphoterine; Hexafluorine; Review

Mesh:

Substances:

Year:  2017        PMID: 28330646     DOI: 10.1016/j.bjps.2017.02.013

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  3 in total

Review 1.  Paediatric chemical burns: a clinical review.

Authors:  Alexander T M Nguyen; Kira Chamberlain; Andrew J A Holland
Journal:  Eur J Pediatr       Date:  2021-01-06       Impact factor: 3.183

2.  Eye wash water flow direction study: an evaluation of the effectiveness of eye wash devices with opposite directional water flow.

Authors:  Jennifer S Fogt; Lisa A Jones-Jordan; Joseph T Barr
Journal:  Clin Ophthalmol       Date:  2018-04-09

3.  Clinical outcomes and safety of Diphoterine® irrigation for chemical eye injury: A single-centre experience in the United Kingdom.

Authors:  Muzammil Ahmad Nahaboo Solim; Teresa Maria Lupion-Duran; Romeela Rana-Rahman; Trushar Patel; Desiree Ah-Kine; Darren S J Ting
Journal:  Ther Adv Ophthalmol       Date:  2021-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.